Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Synovir thalidomide: Began a pilot study in 46 patients, to evaluate quality of life, pain, and joint swelling, and serological indicators of the disease

Celgene Corp. (CELG), Warren,

Read the full 41 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE